Danske Bank A S purchased a new stake in Cigna Group (NYSE:CI – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 134,188 shares of the health services provider’s stock, valued at approximately $36,993,000. Danske Bank A S owned approximately 0.05% of Cigna Group at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in the stock. Assetmark Inc. grew its position in shares of Cigna Group by 10.0% in the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after acquiring an additional 5,963 shares in the last quarter. HighTower Advisors LLC raised its position in shares of Cigna Group by 402.7% during the 2nd quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock valued at $97,701,000 after acquiring an additional 283,897 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Cigna Group by 41.1% during the 4th quarter. Victory Capital Management Inc. now owns 1,348,713 shares of the health services provider’s stock valued at $371,206,000 after acquiring an additional 392,978 shares in the last quarter. Handelsbanken Fonder AB lifted its stake in Cigna Group by 12.1% during the second quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock worth $22,833,000 after purchasing an additional 8,960 shares during the last quarter. Finally, TD Asset Management Inc lifted its stake in Cigna Group by 4.8% during the second quarter. TD Asset Management Inc now owns 249,966 shares of the health services provider’s stock worth $68,911,000 after purchasing an additional 11,471 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.60% of the company’s stock.
Cigna Group Stock Performance
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period last year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities analysts anticipate that Cigna Group will post 30.51 earnings per share for the current year.
Cigna Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s payout ratio is 25.82%.
Analyst Upgrades and Downgrades
Several analysts have weighed in on the stock. Piper Sandler lowered their target price on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. Cantor Fitzgerald raised their price target on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research report on Friday, May 1st. Guggenheim lifted their price target on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Wells Fargo & Company boosted their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Finally, Barclays increased their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $339.45.
Check Out Our Latest Research Report on CI
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
